The Leeds Teaching Hospitals NHS Trust

Service Change Notifications

New or Pending Notifications

Letter to users re: changes to Solid Tissue service [2023]

Previous Notifications (older than 12 months)

Letter to users re: changes to Solid Tissue service [2021]

Letter to users re: changes to microarray service [2019]

Letter to users re: accreditation of DNA extraction facilities reinstated [2019]

Letter to users re: laboratory change of name and address effective 15th July 2019 [2019]

Letter to users re: constitutional genetics testing services [2019]

Letter to users re: somatic cancer genetics testing services [2019]

Changes to current service [2019]

In response to NHS England’s recent Strategy and Service Specification for the future of Genomics services in England, Newcastle Teaching Hospitals, Leeds Teaching Hospitals, Sheffield Children’s Trust, Sheffield Teaching Hospitals and NewGene have formed the Yorkshire and North East Genomic Laboratory Hub (YNEGLH); an exciting collaboration to provide services for Genomics across Yorkshire and Humber and the North.

The Leeds Genetics Service will continue to receive samples, perform genomic tests and dispatch DNA samples for specialist testing to the appropriate laboratory, as part of YNEGLH. We will issue further information about the future genomic testing arrangements as it becomes available.

NHS England are currently producing the National Genomic Test Directory that will specify which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test. The final draft 2018/2019 National Genomic Test Directory for rare and inherited disorders and cancer can be accessed at

Letter to users re: changes to Whipple disease service [2018]

Change to format of oncology reports [2018]

Please note that from 01/01/18 solid tumour and molecular oncology results will be reported and integrated into cellular pathology reports. Separate reports from the Leeds Genetics Lab will no longer be issued.

Letter to users re: change to testing strategy for recurrent miscarriage patients [2017]